These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26090879)

  • 1. Simple Resistance Exercise helps Patients with Non-alcoholic Fatty Liver Disease.
    Takahashi A; Abe K; Usami K; Imaizumi H; Hayashi M; Okai K; Kanno Y; Tanji N; Watanabe H; Ohira H
    Int J Sports Med; 2015 Oct; 36(10):848-52. PubMed ID: 26090879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of aerobic exercise and resistance exercise in improving non-alcoholic fatty liver disease: a randomized controlled trial].
    Jia GY; Han T; Gao L; Wang L; Wang SC; Yang L; Zhang J; Guan YY; Yan NN; Yu HY; Xiao HJ; Di FS
    Zhonghua Gan Zang Bing Za Zhi; 2018 Jan; 26(1):34-41. PubMed ID: 29804360
    [No Abstract]   [Full Text] [Related]  

  • 3. Regular exercise coupled to diet regimen accelerates reduction of hepatic steatosis and associated pathological conditions in nonalcoholic fatty liver disease.
    Oh S; Tanaka K; Tsujimoto T; So R; Shida T; Shoda J
    Metab Syndr Relat Disord; 2014 Jun; 12(5):290-8. PubMed ID: 24689911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of enforced physical inactivity induced by 60-day of bed rest on hepatic markers of NAFLD in healthy normal-weight women.
    Rudwill F; Bergouignan A; Gastebois C; Gauquelin-Koch G; Lefai E; Blanc S; Simon C
    Liver Int; 2015 Jun; 35(6):1700-6. PubMed ID: 25413107
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple resistance exercise decreases cytokeratin 18 and fibroblast growth factor 21 levels in patients with nonalcoholic fatty liver disease: A retrospective clinical study.
    Takahashi A; Abe K; Fujita M; Hayashi M; Okai K; Ohira H
    Medicine (Baltimore); 2020 May; 99(22):e20399. PubMed ID: 32481431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to the Mediterranean diet is associated with the severity of non-alcoholic fatty liver disease.
    Kontogianni MD; Tileli N; Margariti A; Georgoulis M; Deutsch M; Tiniakos D; Fragopoulou E; Zafiropoulou R; Manios Y; Papatheodoridis G
    Clin Nutr; 2014 Aug; 33(4):678-83. PubMed ID: 24064253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simple Resistance Exercise for 24 Weeks Decreases Alanine Aminotransferase Levels in Patients with Non-Alcoholic Fatty Liver Disease.
    Takahashi A; Imaizumi H; Hayashi M; Okai K; Abe K; Usami K; Tanji N; Ohira H
    Sports Med Int Open; 2017 Jan; 1(1):E2-E7. PubMed ID: 30539079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial.
    Chen S; Zhao X; Ran L; Wan J; Wang X; Qin Y; Shu F; Gao Y; Yuan L; Zhang Q; Mi M
    Dig Liver Dis; 2015 Mar; 47(3):226-32. PubMed ID: 25577300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The benefits of exercise for patients with non-alcoholic fatty liver disease.
    Keating SE; George J; Johnson NA
    Expert Rev Gastroenterol Hepatol; 2015; 9(10):1247-50. PubMed ID: 26289101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemoglobin combined with triglyceride and ferritin in predicting non-alcoholic fatty liver.
    Jiang Y; Zeng J; Chen B
    J Gastroenterol Hepatol; 2014; 29(7):1508-14. PubMed ID: 24628002
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified high-intensity interval training reduces liver fat and improves cardiac function in non-alcoholic fatty liver disease: a randomized controlled trial.
    Hallsworth K; Thoma C; Hollingsworth KG; Cassidy S; Anstee QM; Day CP; Trenell MI
    Clin Sci (Lond); 2015 Dec; 129(12):1097-105. PubMed ID: 26265792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial: insulin-sensitizing agents may reduce consequences of insulin resistance in individuals with non-alcoholic steatohepatitis.
    Idilman R; Mizrak D; Corapcioglu D; Bektas M; Doganay B; Sayki M; Coban S; Erden E; Soykan I; Emral R; Uysal AR; Ozden A
    Aliment Pharmacol Ther; 2008 Jul; 28(2):200-8. PubMed ID: 18445142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Individualized exercise prescription in non-alcoholic steatohepatitis: a case report.
    Sánchez-Martos MÁ; Gomis-Díaz JM; Sarabia-Marín JM; Moya-Ramón M; Aracil-Marco A
    Rev Esp Enferm Dig; 2015 Mar; 107(3):178-81. PubMed ID: 25733044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats.
    Elshazly SM
    Eur J Pharmacol; 2015 Feb; 748():123-32. PubMed ID: 25542756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease.
    Pais R; Rusu E; Zilisteanu D; Circiumaru A; Micu L; Voiculescu M; Poynard T; Ratziu V
    Eur J Intern Med; 2015 Jan; 26(1):30-6. PubMed ID: 25553983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lifestyle interventions for patients with nonalcoholic fatty liver disease: a network meta-analysis.
    Zou TT; Zhang C; Zhou YF; Han YJ; Xiong JJ; Wu XX; Chen YP; Zheng MH
    Eur J Gastroenterol Hepatol; 2018 Jul; 30(7):747-755. PubMed ID: 29683979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerobic exercise and non-alcoholic fatty liver disease: a case report.
    Di Mauro D; Pagano F; Magaudda L; Speciale F; Speranza G; Bonaiuto M; Mallamace A; Trimarchi F
    J Sports Med Phys Fitness; 2009 Dec; 49(4):448-52. PubMed ID: 20087305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Markers of liver function and inflammatory cytokines modulation by aerobic versus resisted exercise training for nonalcoholic steatohepatitis patients.
    Abd El-Kader SM; Al-Jiffri OH; Al-Shreef FM
    Afr Health Sci; 2014 Sep; 14(3):551-7. PubMed ID: 25352871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of resveratrol supplementation on cardiovascular risk factors in patients with non-alcoholic fatty liver disease: a randomised, double-blind, placebo-controlled study.
    Faghihzadeh F; Adibi P; Hekmatdoost A
    Br J Nutr; 2015 Sep; 114(5):796-803. PubMed ID: 26234526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of exercise and dietary modification on serum aminotransferase levels in patients with nonalcoholic steatohepatitis.
    Sreenivasa Baba C; Alexander G; Kalyani B; Pandey R; Rastogi S; Pandey A; Choudhuri G
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):191-8. PubMed ID: 16706832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.